Sanguine Biosciences Announces $10 Million Credit Financing from Catalio Capital Management to Fund Continued Growth
Capital infusion fast-tracks the development of apheresis-derived products critical to cell and gene therapy research and manufacturing.
Sep 26, 2023
Sanguine Biosciences Opens New Apheresis Donor Center in Los Angeles
Sangine will collect concentrated white blood cell biospecimens through apheresis from participants in Sanguine’s Southern California Patient Community…
Sep 13, 2023
Sanguine Opens New Apheresis Donor Center to Support Cell & Gene Therapy and Trans...
Jan 09, 2023
Sanguine Biosciences Partners with Broadoak Capital Partners to Accelerate Launch of Ne...
Aug 11, 2022
Fortune Best Small Workplaces – #30 out of 100 in the US
Apr 16, 2021
PODCAST: The Bio Report: Bringing the Trial to the Patient
Apr 04, 2021
Recovered Coronavirus Patient Donates Blood To Help Vaccine, Treatment Research
Aug 03, 2020
Sanguine Bio Accelerates Pace in Vaccine Race
Subscribe to our Newsletter
Select what you would like to receive directly in your email
Patient Newsletter form (Newsletter Subscription Form - B2C)